N/A N=1,390 Real-world Study of Dedifferentiated Liposarcoma Patients in China
Dedifferentiated Liposarcoma
Primary: Cohort 1: Overall Survival — 13.4; 11.9; 8.1 months
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=101 Validation Study of Mean Arterial Pressure (MAP) Parameter of Masimo INVSENSOR00073
Healthy
Primary: Mean Arterial Pressure (MAP) Accuracy and Precision of Masimo INVSENSOR00073 — 1.38 Millimeters of mercury (mmHg)
N/A N=30 Insertion Clinical Study to Evaluate the Orientation Characteristics of Multiple Kalifilcon A Daily Disposable Toric LD213001 Contact Lenses
Astigmatism
Primary: Mean Absolute Primary Gaze Orientation at 3 Minutes for the Lenses Inserted at 90 Degrees — 1.3; 3.3; 2.0; 3.0 degrees
N/A N=55 A Study to Evaluate the Effect of a Stannous Fluoride Toothpaste on the Oral Microbiome
Oral Health
Primary: Alpha Diversity at Baseline (Day 1) — 3.7; 3.5 Shannon index
N/A N=26 A Multi-level Intervention to Increase Access and Use of the Patient Portal
Patient Education · Diabetes Mellitus, Type 2
Primary: Usage of Portal — 12.65; 5.79 days per month
N/A N=3,367 HPV Self-Sampling in Somali Women (Isbaar Project)
Cervical Cancer · Papillomavirus Infection · Uterine Diseases
Primary: Difference-in-difference Comparison — 1.8 Hazard ratio
N/A N=390 Study of an Online Program to Help Parents Talk With Their Tween Children About Health, Gender, Body-Image, and Relationships
Parenting · Parent-Child Relations · Communication
Primary: Change From Pretest in Child Report of Frequency of Parent-child Communication — 2.18; 2.20 score on a scale — p=0.69
Phase 3 N=512 Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution
Allergic Conjunctivitis
Primary: Number of Participants With Treatment Emergent Adverse Events (TEAEs) — 61; 19; 38; 10 Participants
Phase 3 N=116 Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC
Progressive Familial Intrahepatic Cholestasis
Primary: Change From Baseline in Serum Bile Acids — -104.00; -139.84; -57.97 micromole per liter (µmol/L)
Phase 3 N=171 The POUR (Postoperative Urinary Retention) Study
Postoperative Urinary Retention
Primary: Number of Participants With Urinary Retention — 0; 11; 74; 63 Participants
Phase 1 N=12 Study of LY3039478 in Healthy Participants
Healthy
Primary: Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve (AUC) From Time Zero to the Last Time Point With a Measurable Concentration (AUC[0-tlast]) of…
Phase 2 N=663 Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)
Hypertension
Primary: Indapamide: Change From Baseline at Month 3 in 24-hour Mean SBP Assessed by ABPM - Censored Data — -3.7; -15.7 mmHg — p=<0.0001
Phase 2 N=112 A Study in Participants With Non-cirrhotic NASH With Fibrosis
Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
Primary: Relative to Baseline Alanine Aminotransferase (ALT) — 0.959; 0.895 Ratio — p=0.893
Phase 3 N=106 The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy
Proliferative Vitreoretinopathy
Primary: Recurrent Retinal Detachment Compared to Historical Rates — 18.8; 20.6 percentage of subjects
Phase 1 N=14 Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)
Heart Failure With Reduced Ejection Fraction
Primary: Incidence and Severity of Treatment-emergent Adverse Events [Safety and Tolerability] — 4; 3; 8; 2 number of events